Free Trial

Travelers Companies (TRV) Financials

Travelers Companies logo
$265.00 -0.36 (-0.14%)
Closing price 08/8/2025 03:59 PM Eastern
Extended Trading
$263.50 -1.50 (-0.56%)
As of 08/8/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Travelers Companies

Annual Income Statements for Travelers Companies

This table shows Travelers Companies' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders
3,692 3,439 3,014 2,056 2,523 2,622 2,697 3,662 2,842 2,991 4,999
Consolidated Net Income / (Loss)
3,692 3,439 3,014 2,056 2,523 2,622 2,697 3,662 2,842 2,991 4,999
Net Income / (Loss) Continuing Operations
3,692 3,439 3,014 2,056 2,523 2,622 2,697 3,662 2,842 2,991 4,999
Total Pre-Tax Income
5,089 4,740 4,053 2,730 2,961 3,138 3,237 4,458 3,354 3,371 6,180
Total Revenue
26,805 26,442 27,262 28,533 29,930 31,237 31,642 34,476 36,533 40,988 46,031
Net Interest Income / (Expense)
-369 -373 -363 -369 -352 -344 -339 -340 -351 -376 -392
Total Interest Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Expense
369 373 363 369 352 344 339 340 351 376 392
Other Interest Expense
- - 363 369 352 344 - - - - 392
Total Non-Interest Income
27,174 26,815 27,625 28,902 30,282 31,581 31,981 34,816 36,884 41,364 46,423
Other Service Charges
595 559 721 606 635 728 708 757 763 786 922
Net Realized & Unrealized Capital Gains on Investments
2,866 2,382 2,370 2,613 2,588 2,581 2,229 3,204 2,358 2,817 3,560
Premiums Earned
23,713 23,874 24,534 25,683 27,059 28,272 29,044 30,855 33,763 37,761 41,941
Total Non-Interest Expense
21,716 21,702 23,209 25,803 26,969 28,099 28,405 30,018 33,179 37,617 39,851
Property & Liability Insurance Claims
13,870 13,723 15,070 17,467 18,291 19,133 19,123 20,298 22,854 26,215 27,059
Other Operating Expenses
3,964 4,094 4,154 4,170 4,297 4,365 4,509 4,677 4,810 5,176 5,819
Amortization Expense
3,882 3,885 3,985 4,166 4,381 4,601 4,773 5,043 5,515 6,226 6,973
Income Tax Expense
1,397 1,301 1,039 674 438 516 540 796 512 380 1,181
Basic Earnings per Share
$10.82 $10.99 $10.39 $7.39 $9.37 $10.01 $10.56 $14.63 $11.91 $12.93 $21.76
Weighted Average Basic Shares Outstanding
338.80M 310.60M 288.10M 276M 267.40M 260M 253.50M 248.50M 237M 229.70M 228M
Diluted Earnings per Share
$10.70 $10.88 $10.28 $7.33 $9.28 $9.92 $10.52 $14.49 $11.77 $12.79 $21.47
Weighted Average Diluted Shares Outstanding
342.50M 313.90M 291M 278.60M 269.80M 262.30M 254.60M 250.80M 239.70M 232.20M 231.10M
Weighted Average Basic & Diluted Shares Outstanding
341.20M 312.90M 290.10M 278.20M 269.30M 255.03M 252.21M 241.50M 232.09M 229.13M 226.73M
Cash Dividends to Common per Share
$2.15 $2.38 $2.62 $2.83 $3.03 $3.23 $3.37 $3.49 $3.67 $3.93 $4.15

Quarterly Income Statements for Travelers Companies

This table shows Travelers Companies' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders
819 975 -14 404 1,626 1,123 534 1,260 2,082 395 1,509
Consolidated Net Income / (Loss)
819 975 -14 404 1,626 1,123 534 1,260 2,082 395 1,509
Net Income / (Loss) Continuing Operations
819 975 -14 404 1,626 1,123 534 1,260 2,082 395 1,509
Total Pre-Tax Income
987 928 -48 472 2,019 1,370 656 1,560 2,594 468 1,881
Total Revenue
9,548 9,616 10,006 10,537 10,829 11,130 11,185 11,806 11,910 11,711 12,017
Net Interest Income / (Expense)
-88 -88 -92 -98 -98 -98 -98 -98 -98 -99 -99
Total Interest Income
- 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Total Interest Expense
88 88 92 98 98 98 98 98 98 99 99
Long-Term Debt Interest Expense
- 88 92 - - 98 - 98 - 99 99
Total Non-Interest Income
9,636 9,704 10,098 10,635 10,927 11,228 11,283 11,904 12,008 11,810 12,116
Other Service Charges
187 181 205 213 187 221 220 241 240 231 247
Net Realized & Unrealized Capital Gains on Investments
632 669 677 704 767 881 820 959 900 869 948
Premiums Earned
8,817 8,854 9,216 9,718 9,973 10,126 10,243 10,704 10,868 10,710 10,921
Total Non-Interest Expense
8,561 8,688 10,054 10,065 8,810 9,760 10,529 10,246 9,316 11,243 10,136
Property & Liability Insurance Claims
5,924 5,959 7,227 7,149 5,880 6,656 7,373 6,996 6,034 8,006 6,789
Other Operating Expenses
1,203 1,267 1,308 1,312 1,289 1,406 1,478 1,460 1,475 1,459 1,545
Amortization Expense
1,434 1,462 1,519 1,604 1,641 1,698 1,678 1,790 1,807 1,778 1,802
Income Tax Expense
168 -47 -34 68 393 247 122 300 512 73 372
Basic Earnings per Share
$3.51 $4.18 ($0.07) $1.75 $7.07 $4.87 $2.32 $5.50 $9.07 $1.73 $6.63
Weighted Average Basic Shares Outstanding
237M 231.70M 229.70M 228.80M 229.70M 229M 228.60M 227.40M 228M 226.90M 225.90M
Diluted Earnings per Share
$3.46 $4.13 ($0.07) $1.74 $6.99 $4.80 $2.29 $5.42 $8.96 $1.70 $6.53
Weighted Average Diluted Shares Outstanding
239.70M 234.40M 229.70M 231.10M 232.20M 232M 231.50M 230.60M 231.10M 230.40M 229.30M
Weighted Average Basic & Diluted Shares Outstanding
232.09M 230.98M 228.94M 228.40M 229.13M 228.99M 227.93M 227.02M 226.73M 226.57M 225.13M
Cash Dividends to Common per Share
- $0.93 $1.00 $1.00 - $1.00 $1.05 $1.05 - $1.05 $1.10

Annual Cash Flow Statements for Travelers Companies

This table details how cash moves in and out of Travelers Companies' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents
80 6.00 -73 37 29 121 227 40 38 -149 49
Net Cash From Operating Activities
6,834 3,434 4,469 4,148 4,380 5,205 6,519 7,274 6,465 7,711 9,074
Net Cash From Continuing Operating Activities
3,693 3,434 4,469 4,148 4,380 5,205 6,519 7,274 6,465 7,711 9,074
Net Income / (Loss) Continuing Operations
3,692 3,439 3,014 2,056 2,523 2,622 2,697 3,662 2,842 2,991 4,999
Consolidated Net Income / (Loss)
3,692 3,439 3,014 2,056 2,523 2,622 2,697 3,662 2,842 2,991 4,999
Depreciation Expense
- 818 826 813 803 763 789 870 826 722 715
Amortization Expense
3,882 3,885 3,985 4,166 4,381 4,601 4,773 5,043 5,515 6,226 6,973
Non-Cash Adjustments to Reconcile Net Income
-302 -48 266 -233 -592 138 -32 -352 -273 432 140
Changes in Operating Assets and Liabilities, net
-438 -4,660 -3,622 -2,654 -2,735 -2,919 -1,708 -1,949 -2,445 -2,660 -3,753
Net Cash From Investing Activities
206 317 -1,727 -2,202 -2,329 -2,902 -4,892 -5,196 -3,728 -6,821 -7,264
Net Cash From Continuing Investing Activities
206 317 -1,727 -2,202 -2,329 -2,902 -4,892 -5,196 -3,728 -6,821 -7,264
Purchase of Investment Securities
-12,847 -13,439 -12,825 -14,062 -14,310 -12,691 -15,681 -17,754 -16,693 -18,483 -18,120
Sale and/or Maturity of Investments
13,053 13,756 11,098 11,860 12,303 9,789 10,789 12,558 12,965 11,662 10,856
Net Cash From Financing Activities
-3,866 -3,733 -2,806 -1,920 -2,012 -2,187 -1,416 -2,037 -2,669 -1,051 -1,747
Net Cash From Continuing Financing Activities
-3,809 -3,733 -2,806 -1,920 -2,012 -2,187 -1,416 -2,037 -2,669 -1,051 -1,747
Issuance of Debt
0.00 392 491 789 591 492 490 739 0.00 738 0.00
Repurchase of Common Equity
-3,275 -3,150 -2,400 -1,378 -1,270 -1,500 -625 -2,156 -2,000 -958 -1,003
Payment of Dividends
-729 -739 -757 -785 -814 -844 -861 -869 -875 -908 -951
Other Financing Activities, Net
138 164 260 111 81 165 80 249 206 77 207
Effect of Exchange Rate Changes
- -12 -9.00 11 -10 5.00 16 -1.00 -30 12 -14
Cash Interest Paid
- 365 358 367 347 338 339 337 349 370 390
Cash Income Taxes Paid
1,147 1,207 892 514 408 428 578 707 817 201 1,310

Quarterly Cash Flow Statements for Travelers Companies

This table details how cash moves in and out of Travelers Companies' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Change in Cash & Equivalents
26 -32 -162 -12 57 17 62 43 -73 25 -65
Net Cash From Operating Activities
1,340 1,012 1,549 3,046 2,104 1,458 1,677 3,875 2,064 1,360 2,334
Net Cash From Continuing Operating Activities
1,340 1,012 1,549 3,046 2,104 1,458 1,677 3,875 2,064 1,360 2,334
Net Income / (Loss) Continuing Operations
819 975 -14 404 1,626 1,123 534 1,260 2,082 395 1,509
Consolidated Net Income / (Loss)
819 975 -14 404 1,626 1,123 534 1,260 2,082 395 1,509
Depreciation Expense
187 204 179 169 170 196 182 174 163 188 164
Amortization Expense
1,434 1,462 1,519 1,604 1,641 1,698 1,678 1,790 1,807 1,778 1,802
Non-Cash Adjustments to Reconcile Net Income
-23 -693 -19 652 492 -644 -384 785 383 -860 -84
Changes in Operating Assets and Liabilities, net
-1,077 -936 -116 217 -1,825 -915 -333 -134 -2,371 -141 -1,057
Net Cash From Investing Activities
-674 -455 -1,857 -2,725 -1,784 -1,037 -1,143 -3,391 -1,693 -808 -1,716
Net Cash From Continuing Investing Activities
-674 -455 -1,857 -2,725 -1,784 -1,037 -1,143 -3,391 -1,693 -808 -1,716
Purchase of Investment Securities
-3,637 -4,642 -4,021 -6,245 -3,575 -3,875 -3,804 -5,653 -4,334 -4,540 -5,095
Sale and/or Maturity of Investments
2,963 4,187 2,164 3,520 1,791 2,838 2,661 2,262 2,641 3,732 3,379
Net Cash From Financing Activities
-658 -593 138 -323 -273 -399 -472 -454 -422 -535 -702
Net Cash From Continuing Financing Activities
-658 -593 138 -323 -273 -399 -472 -454 -422 -535 -702
Repurchase of Common Equity
-500 -398 -396 -100 -64 -250 -249 -248 -256 -250 -500
Payment of Dividends
-219 -215 -232 -229 -232 -229 -244 -238 -240 -240 -250
Other Financing Activities, Net
61 20 28 6.00 23 80 21 32 74 -45 48
Effect of Exchange Rate Changes
18 4.00 8.00 -10 10 -5.00 - 13 -22 8.00 19
Cash Interest Paid
115 60 115 59 136 60 135 60 135 61 136
Cash Income Taxes Paid
154 -16 155 13 49 24 831 92 363 24 538

Annual Balance Sheets for Travelers Companies

This table presents Travelers Companies' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets
103,078 100,184 100,245 103,483 104,233 110,122 116,764 120,466 115,717 125,978 133,189
Cash and Due from Banks
374 380 307 344 373 494 721 761 799 650 699
Trading Account Securities
64,373 61,363 61,247 63,147 63,832 68,559 74,003 78,703 71,967 78,415 84,353
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accrued Investment Income
685 642 630 606 624 618 603 615 650 688 752
Unearned Premiums Asset
16,236 16,003 15,598 16,004 16,454 16,833 16,951 17,439 18,009 19,575 20,312
Deferred Acquisition Cost
1,835 1,849 1,923 2,025 2,120 2,273 2,358 2,542 2,836 3,306 3,494
Goodwill
3,611 3,573 3,580 3,951 3,937 3,961 3,976 4,008 3,952 3,976 4,233
Intangible Assets
304 279 268 342 345 330 317 306 287 277 360
Other Assets
15,660 16,095 16,692 17,064 16,548 17,054 17,351 16,092 17,217 19,091 18,986
Total Liabilities & Shareholders' Equity
103,078 100,184 100,245 103,483 104,233 110,122 116,764 120,466 115,717 125,978 133,189
Total Liabilities
78,242 76,586 77,024 79,752 81,339 84,179 87,563 91,579 94,157 101,057 105,325
Short-Term Debt
4,362 4,374 4,609 4,775 4,785 4,619 4,261 3,911 3,596 3,269 3,189
Long-Term Debt
6,349 6,344 6,437 6,571 6,564 6,558 6,550 7,290 7,292 8,031 8,033
Claims and Claim Expense
49,850 48,295 47,949 49,650 50,668 51,849 54,521 56,907 58,649 61,627 64,093
Unearned Premiums Liability
12,175 12,267 12,602 13,189 13,844 14,967 15,578 16,853 18,659 21,390 22,839
Other Long-Term Liabilities
5,506 5,306 5,427 5,567 5,478 6,186 6,653 6,618 5,961 6,740 7,171
Total Equity & Noncontrolling Interests
24,836 23,598 23,221 23,731 22,894 25,943 29,201 28,887 21,560 24,921 27,864
Total Preferred & Common Equity
24,836 23,598 23,221 23,731 22,894 25,943 29,201 28,887 21,560 24,921 27,864
Total Common Equity
24,836 23,598 23,221 23,731 22,894 25,943 29,201 28,887 21,560 24,921 27,864
Common Stock
21,843 22,172 22,614 22,886 23,144 23,469 23,743 24,154 24,565 24,906 25,452
Retained Earnings
27,251 29,945 32,196 33,462 35,204 36,977 38,771 41,555 43,516 45,591 49,630
Treasury Stock
-25,138 -28,362 -30,834 -32,274 -33,595 -35,143 -35,815 -38,015 -40,076 -41,105 -42,251
Accumulated Other Comprehensive Income / (Loss)
880 -157 -755 -343 -1,859 640 2,502 1,193 -6,445 -4,471 -4,967

Quarterly Balance Sheets for Travelers Companies

This table presents Travelers Companies' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Total Assets
115,717 118,352 120,573 121,384 125,978 127,410 129,315 134,588 133,189 135,977 138,873
Cash and Due from Banks
799 767 605 593 650 667 729 772 699 724 659
Trading Account Securities
71,967 73,563 73,799 73,157 78,415 78,680 79,832 84,687 84,353 86,044 88,220
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accrued Investment Income
650 594 649 623 688 648 690 665 752 703 785
Unearned Premiums Asset
18,009 18,934 19,750 20,001 19,575 20,464 21,068 20,848 20,312 21,484 21,793
Deferred Acquisition Cost
2,836 3,005 3,212 3,330 3,306 3,380 3,508 3,579 3,494 3,540 3,667
Goodwill
3,952 3,959 3,975 3,955 3,976 4,251 4,250 4,273 4,233 4,245 4,283
Intangible Assets
287 285 283 278 277 376 371 368 360 356 348
Other Assets
17,217 17,245 18,300 19,447 19,091 18,944 18,867 19,396 18,986 18,881 19,118
Total Liabilities & Shareholders' Equity
115,717 118,352 120,573 121,384 125,978 127,410 129,315 134,588 133,189 135,977 138,873
Total Liabilities
94,157 95,300 98,718 101,406 101,057 102,388 104,453 106,892 105,325 107,786 109,355
Short-Term Debt
3,596 3,617 3,469 4,294 3,269 4,172 4,161 4,231 3,189 3,210 3,112
Long-Term Debt
7,292 7,292 8,031 8,031 8,031 8,032 8,032 8,033 8,033 8,033 8,034
Claims and Claim Expense
58,649 59,064 60,571 61,709 61,627 62,487 63,857 64,746 64,093 65,976 66,941
Unearned Premiums Liability
18,659 19,904 20,940 21,058 21,390 21,307 22,090 22,783 22,839 23,816 24,275
Other Long-Term Liabilities
5,961 5,423 5,707 6,314 6,740 6,390 6,313 7,099 7,171 6,751 6,993
Total Equity & Noncontrolling Interests
21,560 23,052 21,855 19,978 24,921 25,022 24,862 27,696 27,864 28,191 29,518
Total Preferred & Common Equity
21,560 23,052 21,855 19,978 24,921 25,022 24,862 27,696 27,864 28,191 29,518
Total Common Equity
21,560 23,052 21,855 19,978 24,921 25,022 24,862 27,696 27,864 28,191 29,518
Common Stock
24,565 24,703 24,776 24,831 24,906 25,163 25,245 25,339 25,452 25,584 25,728
Retained Earnings
43,516 44,273 44,026 44,198 45,591 46,483 46,773 47,789 49,630 49,784 51,041
Treasury Stock
-40,076 -40,538 -40,938 -41,039 -41,105 -41,493 -41,746 -41,999 -42,251 -42,609 -43,166
Accumulated Other Comprehensive Income / (Loss)
-6,445 -5,386 -6,009 -8,012 -4,471 -5,131 -5,410 -3,433 -4,967 -4,568 -4,085

Annual Metrics And Ratios for Travelers Companies

This table displays calculated financial ratios and metrics derived from Travelers Companies' official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics
- - - - - - - - - - -
Revenue Growth
3.77% -1.35% 3.10% 4.66% 4.90% 4.37% 1.30% 8.96% 5.97% 12.19% 12.30%
EBITDA Growth
2.34% 5.26% -6.13% -13.03% 5.66% 4.38% 3.49% 17.87% -6.52% 6.44% 34.39%
EBIT Growth
2.91% -6.86% -14.49% -32.64% 8.46% 5.98% 3.15% 37.72% -24.76% 0.51% 83.33%
NOPAT Growth
0.52% -6.85% -12.36% -31.79% 22.71% 3.92% 2.86% 35.78% -22.39% 5.24% 67.13%
Net Income Growth
0.52% -6.85% -12.36% -31.79% 22.71% 3.92% 2.86% 35.78% -22.39% 5.24% 67.13%
EPS Growth
9.86% 1.68% -5.51% -28.70% 26.60% 6.90% 6.05% 37.74% -18.77% 8.67% 67.87%
Operating Cash Flow Growth
-0.58% -49.75% 30.14% -7.18% 5.59% 18.84% 25.25% 11.58% -11.12% 19.27% 17.68%
Free Cash Flow Firm Growth
-18.68% 19.35% -34.41% -59.32% 169.42% -107.60% 23.53% 1,938.97% 192.30% -107.46% 372.89%
Invested Capital Growth
-0.62% -3.46% -0.14% 2.36% -2.38% 8.40% 7.79% 0.19% -19.06% 11.63% 7.91%
Revenue Q/Q Growth
0.22% -0.45% 1.94% 0.90% 1.19% 0.88% 1.07% 1.80% 1.74% 3.23% 2.40%
EBITDA Q/Q Growth
1.15% 6.26% 12.15% -4.73% -0.88% 4.61% 7.40% 1.13% -5.38% 13.43% 5.59%
EBIT Q/Q Growth
1.78% -5.03% 2.35% -13.93% -3.71% 11.67% 20.11% 0.77% -16.50% 44.12% 10.26%
NOPAT Q/Q Growth
1.37% -4.76% 2.62% -16.01% 2.85% 10.63% 19.34% 0.63% -15.32% 36.95% 10.04%
Net Income Q/Q Growth
1.37% -4.76% 2.62% -16.01% 2.85% 10.63% 19.34% 0.63% -15.32% 36.95% 10.04%
EPS Q/Q Growth
3.98% -2.51% 4.68% -14.97% 3.57% 11.34% 20.50% 1.54% -13.77% 38.12% 10.10%
Operating Cash Flow Q/Q Growth
24.21% -39.79% 216.95% -15.19% 6.96% 9.79% 8.11% -2.79% -5.16% 11.00% -0.44%
Free Cash Flow Firm Q/Q Growth
23.83% 3.02% -0.78% -49.90% -5.17% 4.85% -387.50% 15.71% -14.07% -192.54% 168.53%
Invested Capital Q/Q Growth
-2.68% -3.62% -3.35% -0.96% -0.25% 0.41% 1.90% 0.71% 4.79% 12.13% -2.19%
Profitability Metrics
- - - - - - - - - - -
EBITDA Margin
33.47% 35.71% 32.51% 27.02% 27.21% 27.22% 27.81% 30.08% 26.54% 25.18% 30.13%
EBIT Margin
18.99% 17.93% 14.87% 9.57% 9.89% 10.05% 10.23% 12.93% 9.18% 8.22% 13.43%
Profit (Net Income) Margin
13.77% 13.01% 11.06% 7.21% 8.43% 8.39% 8.52% 10.62% 7.78% 7.30% 10.86%
Tax Burden Percent
72.55% 72.55% 74.36% 75.31% 85.21% 83.56% 83.32% 82.14% 84.73% 88.73% 80.89%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
27.45% 27.45% 25.64% 24.69% 14.79% 16.44% 16.68% 17.86% 15.27% 11.27% 19.11%
Return on Invested Capital (ROIC)
10.35% 9.85% 8.79% 5.93% 7.28% 7.35% 6.99% 9.14% 7.84% 8.71% 13.28%
ROIC Less NNEP Spread (ROIC-NNEP)
10.35% 9.85% 8.79% 5.93% 7.28% 7.35% 6.99% 9.14% 7.84% 8.71% 13.28%
Return on Net Nonoperating Assets (RNNOA)
4.52% 4.36% 4.09% 2.83% 3.54% 3.39% 2.79% 3.46% 3.43% 4.16% 5.66%
Return on Equity (ROE)
14.88% 14.20% 12.88% 8.76% 10.82% 10.74% 9.78% 12.61% 11.27% 12.87% 18.94%
Cash Return on Invested Capital (CROIC)
10.97% 13.37% 8.93% 3.59% 9.69% -0.71% -0.51% 8.95% 28.90% -2.28% 5.67%
Operating Return on Assets (OROA)
4.92% 4.66% 4.04% 2.68% 2.85% 2.93% 2.85% 3.76% 2.84% 2.79% 4.77%
Return on Assets (ROA)
3.57% 3.38% 3.01% 2.02% 2.43% 2.45% 2.38% 3.09% 2.41% 2.48% 3.86%
Return on Common Equity (ROCE)
14.88% 14.20% 12.88% 8.76% 10.82% 10.74% 9.78% 12.61% 11.27% 12.87% 18.94%
Return on Equity Simple (ROE_SIMPLE)
14.87% 14.57% 12.98% 8.66% 11.02% 10.11% 9.24% 12.68% 13.18% 12.00% 17.94%
Net Operating Profit after Tax (NOPAT)
3,692 3,439 3,014 2,056 2,523 2,622 2,697 3,662 2,842 2,991 4,999
NOPAT Margin
13.77% 13.01% 11.06% 7.21% 8.43% 8.39% 8.52% 10.62% 7.78% 7.30% 10.86%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
81.01% 82.07% 85.13% 90.43% 90.11% 89.95% 89.77% 87.07% 90.82% 91.78% 86.57%
Earnings before Interest and Taxes (EBIT)
5,089 4,740 4,053 2,730 2,961 3,138 3,237 4,458 3,354 3,371 6,180
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
8,971 9,443 8,864 7,709 8,145 8,502 8,799 10,371 9,695 10,319 13,868
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.14 1.20 1.26 1.35 1.22 1.23 1.13 1.26 1.96 1.71 1.96
Price to Tangible Book Value (P/TBV)
1.35 1.43 1.51 1.65 1.50 1.47 1.32 1.48 2.44 2.07 2.35
Price to Revenue (P/Rev)
1.05 1.07 1.07 1.12 0.93 1.02 1.04 1.06 1.15 1.04 1.19
Price to Earnings (P/E)
7.65 8.22 9.72 15.56 11.09 12.16 12.22 9.96 14.84 14.29 10.94
Dividend Yield
2.52% 2.56% 2.54% 2.42% 2.87% 2.61% 2.59% 2.35% 2.04% 2.10% 1.72%
Earnings Yield
13.08% 12.17% 10.29% 6.43% 9.02% 8.22% 8.18% 10.04% 6.74% 7.00% 9.14%
Enterprise Value to Invested Capital (EV/IC)
1.08 1.13 1.17 1.23 1.14 1.15 1.08 1.17 1.61 1.47 1.67
Enterprise Value to Revenue (EV/Rev)
1.44 1.46 1.47 1.51 1.30 1.36 1.36 1.36 1.43 1.30 1.42
Enterprise Value to EBITDA (EV/EBITDA)
4.30 4.09 4.52 5.58 4.78 5.01 4.89 4.52 5.39 5.17 4.70
Enterprise Value to EBIT (EV/EBIT)
7.58 8.14 9.88 15.75 13.15 13.57 13.30 10.53 15.59 15.84 10.55
Enterprise Value to NOPAT (EV/NOPAT)
10.45 11.23 13.28 20.91 15.44 16.24 15.96 12.81 18.39 17.85 13.04
Enterprise Value to Operating Cash Flow (EV/OCF)
5.64 11.24 8.96 10.37 8.89 8.18 6.60 6.45 8.09 6.92 7.19
Enterprise Value to Free Cash Flow (EV/FCFF)
9.86 8.27 13.07 34.51 11.60 0.00 0.00 13.09 4.99 0.00 30.56
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.43 0.45 0.48 0.48 0.50 0.43 0.37 0.39 0.51 0.45 0.40
Long-Term Debt to Equity
0.26 0.27 0.28 0.28 0.29 0.25 0.22 0.25 0.34 0.32 0.29
Financial Leverage
0.44 0.44 0.46 0.48 0.49 0.46 0.40 0.38 0.44 0.48 0.43
Leverage Ratio
4.17 4.20 4.28 4.34 4.46 4.39 4.11 4.08 4.68 5.20 4.91
Compound Leverage Factor
4.17 4.20 4.28 4.34 4.46 4.39 4.11 4.08 4.68 5.20 4.91
Debt to Total Capital
30.13% 31.23% 32.24% 32.35% 33.14% 30.11% 27.02% 27.94% 33.56% 31.20% 28.71%
Short-Term Debt to Total Capital
12.27% 12.75% 13.45% 13.61% 13.97% 12.44% 10.65% 9.76% 11.08% 9.03% 8.16%
Long-Term Debt to Total Capital
17.86% 18.49% 18.78% 18.73% 19.17% 17.67% 16.37% 18.19% 22.47% 22.17% 20.55%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
69.87% 68.77% 67.76% 67.65% 66.86% 69.89% 72.98% 72.06% 66.44% 68.80% 71.29%
Debt to EBITDA
1.19 1.14 1.25 1.47 1.39 1.31 1.23 1.08 1.12 1.10 0.81
Net Debt to EBITDA
1.15 1.09 1.21 1.43 1.35 1.26 1.15 1.01 1.04 1.03 0.76
Long-Term Debt to EBITDA
0.71 0.67 0.73 0.85 0.81 0.77 0.74 0.70 0.75 0.78 0.58
Debt to NOPAT
2.90 3.12 3.66 5.52 4.50 4.26 4.01 3.06 3.83 3.78 2.24
Net Debt to NOPAT
2.80 3.01 3.56 5.35 4.35 4.07 3.74 2.85 3.55 3.56 2.11
Long-Term Debt to NOPAT
1.72 1.84 2.14 3.20 2.60 2.50 2.43 1.99 2.57 2.69 1.61
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
3,913 4,670 3,063 1,246 3,357 -255 -195 3,586 10,482 -782 2,134
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
10.60 12.52 8.44 3.38 9.54 -0.74 -0.58 10.55 29.86 -2.08 5.44
Operating Cash Flow to Interest Expense
18.52 9.21 12.31 11.24 12.44 15.13 19.23 21.39 18.42 20.51 23.15
Operating Cash Flow Less CapEx to Interest Expense
18.52 9.21 12.31 11.24 12.44 15.13 19.23 21.39 18.42 20.51 23.15
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.26 0.26 0.27 0.28 0.29 0.29 0.28 0.29 0.31 0.34 0.36
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
35,547 34,316 34,267 35,077 34,243 37,120 40,012 40,088 32,448 36,221 39,086
Invested Capital Turnover
0.75 0.76 0.80 0.82 0.86 0.88 0.82 0.86 1.01 1.19 1.22
Increase / (Decrease) in Invested Capital
-221 -1,231 -49 810 -834 2,877 2,892 76 -7,640 3,773 2,865
Enterprise Value (EV)
38,563 38,606 40,030 42,994 38,952 42,579 43,054 46,924 52,275 53,381 65,210
Market Capitalization
28,226 28,268 29,291 31,992 27,976 31,896 32,964 36,484 42,186 42,731 54,687
Book Value per Share
$74.94 $77.57 $81.75 $86.71 $86.43 $100.51 $115.28 $117.42 $92.00 $109.11 $122.74
Tangible Book Value per Share
$63.13 $64.91 $68.20 $71.02 $70.27 $83.89 $98.33 $99.89 $73.91 $90.49 $102.51
Total Capital
35,547 34,316 34,267 35,077 34,243 37,120 40,012 40,088 32,448 36,221 39,086
Total Debt
10,711 10,718 11,046 11,346 11,349 11,177 10,811 11,201 10,888 11,300 11,222
Total Long-Term Debt
6,349 6,344 6,437 6,571 6,564 6,558 6,550 7,290 7,292 8,031 8,033
Net Debt
10,337 10,338 10,739 11,002 10,976 10,683 10,090 10,440 10,089 10,650 10,523
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Obligations (NNO)
10,711 10,718 11,046 11,346 11,349 11,177 10,811 11,201 10,888 11,300 11,222
Total Depreciation and Amortization (D&A)
3,882 4,703 4,811 4,979 5,184 5,364 5,562 5,913 6,341 6,948 7,688
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $10.01 $10.56 $14.63 $11.91 $12.93 $21.76
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 0.00 0.00 0.00 260M 253.50M 248.50M 237M 229.70M 228M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $9.92 $10.52 $14.49 $11.77 $12.79 $21.47
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 0.00 0.00 0.00 262.30M 254.60M 250.80M 239.70M 232.20M 231.10M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 0.00 0.00 255.03M 252.21M 241.50M 232.09M 229.13M 226.73M
Normalized Net Operating Profit after Tax (NOPAT)
3,692 3,439 3,014 2,056 2,523 2,622 2,697 3,662 2,842 2,991 4,999
Normalized NOPAT Margin
13.77% 13.01% 11.06% 7.21% 8.43% 8.39% 8.52% 10.62% 7.78% 7.30% 10.86%
Pre Tax Income Margin
18.99% 17.93% 14.87% 9.57% 9.89% 10.05% 10.23% 12.93% 9.18% 8.22% 13.43%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
13.79 12.71 11.17 7.40 8.41 9.12 9.55 13.11 9.56 8.97 15.77
NOPAT to Interest Expense
10.01 9.22 8.30 5.57 7.17 7.62 7.96 10.77 8.10 7.95 12.75
EBIT Less CapEx to Interest Expense
13.79 12.71 11.17 7.40 8.41 9.12 9.55 13.11 9.56 8.97 15.77
NOPAT Less CapEx to Interest Expense
10.01 9.22 8.30 5.57 7.17 7.62 7.96 10.77 8.10 7.95 12.75
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
19.75% 21.49% 25.12% 38.18% 32.26% 32.19% 31.92% 23.73% 30.79% 30.36% 19.02%
Augmented Payout Ratio
108.45% 113.09% 104.74% 105.20% 82.60% 89.40% 55.10% 82.61% 101.16% 62.39% 39.09%

Quarterly Metrics And Ratios for Travelers Companies

This table displays calculated financial ratios and metrics derived from Travelers Companies' official financial filings.

Metric Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
7.00% 10.25% 10.59% 14.35% 13.42% 15.74% 11.78% 12.04% 9.98% 5.22% 7.44%
EBITDA Growth
-17.44% -4.84% -26.08% 5.45% 46.86% 25.83% 52.48% 56.97% 19.16% -25.43% 52.90%
EBIT Growth
-40.18% -21.49% -107.31% -10.61% 104.56% 47.63% 1,466.67% 230.51% 28.48% -65.84% 186.74%
NOPAT Growth
-38.56% -4.22% -106.10% -11.01% 98.53% 15.18% 1,689.29% 211.88% 28.04% -64.83% 182.58%
Net Income Growth
-38.56% -4.22% -102.54% -11.01% 98.53% 15.18% 3,914.29% 211.88% 28.04% -64.83% 182.58%
EPS Growth
-35.21% -0.48% -103.08% -7.94% 102.02% 16.22% 3,371.43% 211.49% 28.18% -64.58% 185.15%
Operating Cash Flow Growth
-20.80% -20.06% 12.65% 22.62% 57.01% 44.07% 8.26% 27.22% -1.90% -6.72% 39.18%
Free Cash Flow Firm Growth
572.95% 10.96% -92.56% -110.06% -125.38% -157.03% -698.04% -584.17% 63.53% 15.36% 33.67%
Invested Capital Growth
-19.06% -7.57% -1.66% 4.32% 11.63% 9.61% 11.09% 23.70% 7.91% 5.93% 9.74%
Revenue Q/Q Growth
3.61% 0.71% 4.06% 5.31% 2.77% 2.78% 0.49% 5.55% 0.88% -1.67% 2.61%
EBITDA Q/Q Growth
22.50% -0.54% -36.39% 36.06% 70.60% -14.78% -22.92% 40.06% 29.51% -46.67% 58.05%
EBIT Q/Q Growth
86.93% -5.98% -105.17% 1,083.33% 327.75% -32.14% -52.12% 137.80% 66.28% -81.96% 301.92%
NOPAT Q/Q Growth
80.40% 19.05% -103.45% 1,302.38% 302.48% -30.93% -52.45% 135.96% 65.24% -81.03% 282.03%
Net Income Q/Q Growth
80.40% 19.05% -101.44% 2,985.71% 302.48% -30.93% -52.45% 135.96% 65.24% -81.03% 282.03%
EPS Q/Q Growth
83.07% 19.36% -101.69% 2,585.71% 301.72% -31.33% -52.29% 136.68% 65.31% -81.03% 284.12%
Operating Cash Flow Q/Q Growth
-46.05% -24.48% 53.06% 96.64% -30.93% -30.70% 15.02% 131.07% -46.74% -34.11% 71.62%
Free Cash Flow Firm Q/Q Growth
-9.01% -55.60% -85.91% -276.62% -129.63% 0.23% -47.81% -102.05% 87.76% -131.55% -15.83%
Invested Capital Q/Q Growth
4.79% 4.66% -1.78% -3.15% 12.13% 2.77% -0.46% 7.84% -2.19% 0.89% 3.12%
Profitability Metrics
- - - - - - - - - - -
EBITDA Margin
27.31% 26.98% 16.49% 21.31% 35.37% 29.33% 22.49% 29.85% 38.32% 20.78% 32.01%
EBIT Margin
10.34% 9.65% -0.48% 4.48% 18.64% 12.31% 5.87% 13.21% 21.78% 4.00% 15.65%
Profit (Net Income) Margin
8.58% 10.14% -0.14% 3.83% 15.02% 10.09% 4.77% 10.67% 17.48% 3.37% 12.56%
Tax Burden Percent
82.98% 105.06% 29.17% 85.59% 80.53% 81.97% 81.40% 80.77% 80.26% 84.40% 80.22%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
17.02% -5.06% 0.00% 14.41% 19.47% 18.03% 18.60% 19.23% 19.74% 15.60% 19.78%
Return on Invested Capital (ROIC)
8.64% 10.73% -0.38% 4.81% 17.93% 12.05% 5.92% 13.28% 21.37% 4.10% 15.33%
ROIC Less NNEP Spread (ROIC-NNEP)
8.64% 10.73% -0.21% 4.81% 17.93% 12.05% 5.92% 13.28% 21.37% 4.10% 15.33%
Return on Net Nonoperating Assets (RNNOA)
3.78% 4.89% -0.11% 2.82% 8.56% 5.79% 3.00% 6.85% 9.12% 1.81% 6.58%
Return on Equity (ROE)
12.42% 15.62% -0.49% 7.63% 26.48% 17.84% 8.93% 20.13% 30.49% 5.91% 21.91%
Cash Return on Invested Capital (CROIC)
28.90% 15.78% 8.32% 2.67% -2.28% -0.35% -0.04% -8.62% 5.67% 5.38% 4.21%
Operating Return on Assets (OROA)
3.20% 3.05% -0.16% 1.51% 6.32% 4.26% 2.05% 4.64% 7.74% 1.41% 5.54%
Return on Assets (ROA)
2.65% 3.20% -0.05% 1.29% 5.09% 3.49% 1.67% 3.75% 6.21% 1.19% 4.44%
Return on Common Equity (ROCE)
12.42% 15.62% -0.49% 7.63% 26.48% 17.84% 8.93% 20.13% 30.49% 5.91% 21.91%
Return on Equity Simple (ROE_SIMPLE)
0.00% 12.14% 10.22% 10.93% 0.00% 12.55% 14.83% 16.40% 0.00% 15.15% 17.77%
Net Operating Profit after Tax (NOPAT)
819 975 -34 404 1,626 1,123 534 1,260 2,082 395 1,509
NOPAT Margin
8.58% 10.14% -0.34% 3.83% 15.02% 10.09% 4.77% 10.67% 17.48% 3.37% 12.56%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% -0.17% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
89.66% 90.35% 100.48% 95.52% 81.36% 87.69% 94.14% 86.79% 78.22% 96.00% 84.35%
Earnings before Interest and Taxes (EBIT)
987 928 -48 472 2,019 1,370 656 1,560 2,594 468 1,881
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
2,608 2,594 1,650 2,245 3,830 3,264 2,516 3,524 4,564 2,434 3,847
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.96 1.68 1.80 1.84 1.71 2.09 1.87 1.93 1.96 2.13 2.05
Price to Tangible Book Value (P/TBV)
2.44 2.06 2.23 2.33 2.07 2.56 2.30 2.31 2.35 2.54 2.44
Price to Revenue (P/Rev)
1.15 1.03 1.02 0.92 1.04 1.23 1.07 1.19 1.19 1.29 1.28
Price to Earnings (P/E)
14.84 13.84 17.58 16.79 14.29 16.66 12.63 11.75 10.94 14.04 11.55
Dividend Yield
2.04% 2.23% 2.23% 2.41% 2.10% 1.75% 1.99% 1.75% 1.72% 1.59% 1.59%
Earnings Yield
6.74% 7.23% 5.69% 5.96% 7.00% 6.00% 7.92% 8.51% 9.14% 7.12% 8.65%
Enterprise Value to Invested Capital (EV/IC)
1.61 1.44 1.50 1.50 1.47 1.72 1.57 1.62 1.67 1.79 1.75
Enterprise Value to Revenue (EV/Rev)
1.43 1.31 1.31 1.22 1.30 1.50 1.33 1.44 1.42 1.51 1.50
Enterprise Value to EBITDA (EV/EBITDA)
5.39 5.11 5.59 5.32 5.17 5.81 4.89 4.94 4.70 5.41 4.95
Enterprise Value to EBIT (EV/EBIT)
15.59 15.76 20.95 20.69 15.84 16.74 12.85 11.57 10.55 13.35 10.93
Enterprise Value to NOPAT (EV/NOPAT)
18.39 17.46 22.46 22.16 17.85 20.34 15.74 14.28 13.04 16.50 13.55
Enterprise Value to Operating Cash Flow (EV/OCF)
8.09 7.87 7.86 6.97 6.92 7.83 7.00 7.12 7.19 7.85 7.38
Enterprise Value to Free Cash Flow (EV/FCFF)
4.99 8.76 17.94 57.28 0.00 0.00 0.00 0.00 30.56 34.16 43.44
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.51 0.47 0.53 0.62 0.45 0.49 0.49 0.44 0.40 0.40 0.38
Long-Term Debt to Equity
0.34 0.32 0.37 0.40 0.32 0.32 0.32 0.29 0.29 0.28 0.27
Financial Leverage
0.44 0.46 0.50 0.59 0.48 0.48 0.51 0.52 0.43 0.44 0.43
Leverage Ratio
4.68 4.88 5.30 5.91 5.20 5.11 5.35 5.37 4.91 4.95 4.93
Compound Leverage Factor
4.68 4.88 5.30 5.91 5.20 5.11 5.35 5.37 4.91 4.95 4.93
Debt to Total Capital
33.56% 32.12% 34.48% 38.15% 31.20% 32.78% 32.91% 30.69% 28.71% 28.51% 27.41%
Short-Term Debt to Total Capital
11.08% 10.65% 10.40% 13.29% 9.03% 11.21% 11.23% 10.59% 8.16% 8.14% 7.65%
Long-Term Debt to Total Capital
22.47% 21.47% 24.08% 24.86% 22.17% 21.58% 21.68% 20.10% 20.55% 20.37% 19.76%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
66.44% 67.88% 65.52% 61.85% 68.80% 67.22% 67.09% 69.31% 71.29% 71.49% 72.59%
Debt to EBITDA
1.12 1.14 1.28 1.35 1.10 1.11 1.03 0.93 0.81 0.86 0.78
Net Debt to EBITDA
1.04 1.06 1.21 1.29 1.03 1.05 0.97 0.88 0.76 0.81 0.73
Long-Term Debt to EBITDA
0.75 0.76 0.89 0.88 0.78 0.73 0.68 0.61 0.58 0.62 0.56
Debt to NOPAT
3.83 3.90 5.15 5.64 3.78 3.89 3.31 2.70 2.24 2.63 2.12
Net Debt to NOPAT
3.55 3.62 4.88 5.37 3.56 3.68 3.11 2.53 2.11 2.46 2.00
Long-Term Debt to NOPAT
2.57 2.61 3.59 3.68 2.69 2.56 2.18 1.77 1.61 1.88 1.53
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
8,459 3,756 529 -935 -2,147 -2,142 -3,166 -6,397 -783 -1,813 -2,100
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
96.13 42.68 5.75 -9.54 -21.91 -21.86 -32.31 -65.28 -7.99 -18.31 -21.21
Operating Cash Flow to Interest Expense
15.23 11.50 16.84 31.08 21.47 14.88 17.11 39.54 21.06 13.74 23.58
Operating Cash Flow Less CapEx to Interest Expense
15.23 11.50 16.84 31.08 21.47 14.88 17.11 39.54 21.06 13.74 23.58
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.31 0.32 0.32 0.34 0.34 0.35 0.35 0.35 0.36 0.35 0.35
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
32,448 33,961 33,355 32,303 36,221 37,226 37,055 39,960 39,086 39,434 40,664
Invested Capital Turnover
1.01 1.06 1.14 1.26 1.19 1.19 1.24 1.24 1.22 1.22 1.22
Increase / (Decrease) in Invested Capital
-7,640 -2,781 -563 1,339 3,773 3,265 3,700 7,657 2,865 2,208 3,609
Enterprise Value (EV)
52,275 48,869 50,165 48,405 53,381 63,842 58,028 64,855 65,210 70,479 71,103
Market Capitalization
42,186 38,727 39,270 36,673 42,731 52,305 46,564 53,363 54,687 59,960 60,616
Book Value per Share
$92.00 $99.32 $94.62 $87.26 $109.11 $109.27 $108.57 $121.51 $122.74 $124.34 $130.28
Tangible Book Value per Share
$73.91 $81.04 $76.19 $68.77 $90.49 $89.06 $88.39 $101.15 $102.51 $104.05 $109.84
Total Capital
32,448 33,961 33,355 32,303 36,221 37,226 37,055 39,960 39,086 39,434 40,664
Total Debt
10,888 10,909 11,500 12,325 11,300 12,204 12,193 12,264 11,222 11,243 11,146
Total Long-Term Debt
7,292 7,292 8,031 8,031 8,031 8,032 8,032 8,033 8,033 8,033 8,034
Net Debt
10,089 10,142 10,895 11,732 10,650 11,537 11,464 11,492 10,523 10,519 10,487
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)
0.00 0.00 -20 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Obligations (NNO)
10,888 10,909 11,500 12,325 11,300 12,204 12,193 12,264 11,222 11,243 11,146
Total Depreciation and Amortization (D&A)
1,621 1,666 1,698 1,773 1,811 1,894 1,860 1,964 1,970 1,966 1,966
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$3.51 $4.18 ($0.07) $1.75 $7.07 $4.87 $2.32 $5.50 $9.07 $1.73 $6.63
Adjusted Weighted Average Basic Shares Outstanding
237M 231.70M 229.70M 228.80M 229.70M 229M 228.60M 227.40M 228M 226.90M 225.90M
Adjusted Diluted Earnings per Share
$3.46 $4.13 ($0.07) $1.74 $6.99 $4.80 $2.29 $5.42 $8.96 $1.70 $6.53
Adjusted Weighted Average Diluted Shares Outstanding
239.70M 234.40M 229.70M 231.10M 232.20M 232M 231.50M 230.60M 231.10M 230.40M 229.30M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
232.09M 230.98M 228.94M 228.40M 229.13M 228.99M 227.93M 227.02M 226.73M 226.57M 225.13M
Normalized Net Operating Profit after Tax (NOPAT)
819 650 -34 404 1,626 1,123 534 1,260 2,082 395 1,509
Normalized NOPAT Margin
8.58% 6.76% -0.34% 3.83% 15.02% 10.09% 4.77% 10.67% 17.48% 3.37% 12.56%
Pre Tax Income Margin
10.34% 9.65% -0.48% 4.48% 18.64% 12.31% 5.87% 13.21% 21.78% 4.00% 15.65%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
11.22 10.55 -0.52 4.82 20.60 13.98 6.69 15.92 26.47 4.73 19.00
NOPAT to Interest Expense
9.31 11.08 -0.37 4.12 16.59 11.46 5.45 12.86 21.24 3.99 15.24
EBIT Less CapEx to Interest Expense
11.22 10.55 -0.52 4.82 20.60 13.98 6.69 15.92 26.47 4.73 19.00
NOPAT Less CapEx to Interest Expense
9.31 11.08 -0.37 4.12 16.59 11.46 5.45 12.86 21.24 3.99 15.24
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
30.79% 31.33% 39.66% 40.98% 30.36% 29.37% 25.33% 20.76% 19.02% 22.52% 18.45%
Augmented Payout Ratio
101.16% 99.14% 119.96% 104.81% 62.39% 55.18% 43.31% 38.61% 39.09% 46.01% 42.36%

Key Financial Trends

Travelers Companies (NYSE: TRV) has demonstrated solid financial performance with several positive trends and a few areas to monitor over the past two years up to Q2 2025.

Positive factors:

  • Consistent positive net income growth: The company reported a substantial increase in consolidated net income, rising from $819 million in Q4 2022 to $1.51 billion in Q2 2025, reflecting improving profitability.
  • Strong operating cash flow generation: Net cash from operating activities increased significantly to $2.33 billion in Q2 2025 from $1.34 billion in Q4 2022, indicating healthy cash generation from core operations.
  • Stable premium income: Premiums earned steadily increased from approximately $8.8 billion in Q4 2022 to over $10.9 billion in Q2 2025, showing resilient core insurance revenue.
  • Effective capital returns to shareholders: The company maintained buybacks and dividend payments, with over $500 million repurchased and $250 million paid in dividends in Q2 2025, highlighting shareholder-friendly capital management.
  • Robust total equity growth: Total common equity increased to about $29.5 billion in Q2 2025 from $21.6 billion in Q4 2022, strengthening the company's capital base and financial stability.
  • Amortization and depreciation expenses held steady: Amortization around $1.8 billion and depreciation near $164 million in Q2 2025 reflect consistent non-cash charges and asset management.
  • Net realized and unrealized capital gains rose: Gains on investments increased from about $632 million in Q4 2022 to approximately $948 million in Q2 2025, supporting investment income.
  • Solid total assets growth: The company's total assets grew from $115.7 billion at the end of 2022 to nearly $138.9 billion in Q2 2025, driven by increases in trading securities and unearned premiums assets.

Neutral factors:

  • Interest expense remained relatively stable: Total interest expense held around $88-$99 million per quarter, consistent with steady debt levels.
  • Cash position showed slight volatility: Cash and cash equivalents fluctuated but remained within a manageable range around $600-$700 million.

Negative factors:

  • Increase in claims and claim expenses: Claims expense rose significantly from $58.6 billion in Q4 2022 to nearly $67.0 billion in Q2 2025, potentially pressuring underwriting results.
  • Decline in net interest income: Due to consistent interest expenses and essentially zero interest income, the company recorded negative net interest income, which slightly reduced profitability.
  • Non-interest expenses remain high: Other operating expenses and amortization costs remained high, limiting margin expansion.
  • Fluctuations in comprehensive income: Accumulated other comprehensive loss increased somewhat, possibly due to market or currency impacts.
  • Negative net income in Q2 2023: There was a notable loss in Q2 2023, reflecting potential volatility or market challenges in that quarter.
  • Investing activities cash outflows: The company consistently showed negative net cash flow from investing activities as it continued purchasing securities more than selling, indicating significant capital deployment.
  • Increased short-term debt: Short-term debt increased from about $3.6 billion in Q1 2023 to $3.1 billion in Q2 2025 after peaking at $4.2 billion in earlier quarters, indicating potential liquidity management needs.

Summary: Travelers Companies has shown strong earnings growth, healthy operating cash flows, increasing equity capital, and a stable premium base, illustrating a solid financial foundation. However, rising claims costs and steady high expenses warrant attention. The company’s disciplined share repurchases and dividends reflect confidence in its long-term prospects. Overall, the financials present a positive outlook with some caution on claim expense trends.

08/09/25 09:51 AMAI Generated. May Contain Errors.

Frequently Asked Questions About Travelers Companies' Financials

When does Travelers Companies' fiscal year end?

According to the most recent income statement we have on file, Travelers Companies' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Travelers Companies' net income changed over the last 10 years?

Travelers Companies' net income appears to be on an upward trend, with a most recent value of $5.00 billion in 2024, rising from $3.69 billion in 2014. The previous period was $2.99 billion in 2023. See Travelers Companies' forecast for analyst expectations on what’s next for the company.

How has Travelers Companies' revenue changed over the last 10 years?

Over the last 10 years, Travelers Companies' total revenue changed from $26.81 billion in 2014 to $46.03 billion in 2024, a change of 71.7%.

How much debt does Travelers Companies have?

Travelers Companies' total liabilities were at $105.33 billion at the end of 2024, a 4.2% increase from 2023, and a 34.6% increase since 2014.

How much cash does Travelers Companies have?

In the past 10 years, Travelers Companies' cash and equivalents has ranged from $307 million in 2016 to $799 million in 2022, and is currently $699 million as of their latest financial filing in 2024.

How has Travelers Companies' book value per share changed over the last 10 years?

Over the last 10 years, Travelers Companies' book value per share changed from 74.94 in 2014 to 122.74 in 2024, a change of 63.8%.



This page (NYSE:TRV) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners